< Back to scientific publications

Magazine 14.17

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First ItalianζoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Chiesa V, Dainese F, De Maria G, Didato G, Falcicchio G, Fanella M, Ferlazzo E, Fisco G, Gangitano M, Giallonardo AT, Giorgi FS, La Neve A, Mecarelli O, Montalenti E, Piazza F, Pulitano P, Quarato PP, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership.

Date: 2021

Scope of interest: Epilepsy




You may also be interested in:

Magazine 4.2

Humoral immunity induced by mRNA COVID-19 vaccines in Nursing Home Residents previously infected with SARS-CoV-2. 

Authors: Fedele G, Palmieri A, Damiano C, Di Lonardo A, Leone P, Schiavoni I, Trevisan C, Abbatecola AM, Cafariello C, Malara A, Minchella P, Panduri G, Antonelli Incalzi R, Palamara AT, Stefanelli P, Onder G; GeroCovid Vax Study Group.

Date: 2022

Scope of interest: ageing, geriatrics


Read details
Magazine

A case of metachronousperipheral T-Cell non-Hodgkin lymphoma following chemotherapy for Hodgkin diseasesuccessfullytreated with Brentuximab Vedotin

Authors: Meconi F,Provenzano I, Nasso D, Mariotti B, Pupo L, Secchi R, Cerretti R, Lucia A, Arcese W, Cantonetti M

Date: 2020

Scope of interest: Haematology


Read details
Report/Poster of Convention/Congress Act

The therapeutic management of the elderly affected by COVID-19 in the various settings

Authors: Abatecola Angela Marie

Date: 2020

Scope of interest: Long term care


Read details